Fangyin Dai Selected Research

Fibroins (Fibroin)

1/2022	Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis.
3/2021	Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer.
12/2020	Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics.
10/2020	Injectable, Thixotropic, and Multiresponsive Silk Fibroin Hydrogel for Localized and Synergistic Tumor Therapy.
2/2020	Topical application of silk fibroin-based hydrogel in preventing hypertrophic scars.
1/2019	Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fangyin Dai Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 06/2015
7	Wounds and Injuries (Trauma) 10/2022 - 10/2018
5	Bacterial Infections (Bacterial Infection) 01/2022 - 10/2018
4	Inflammation (Inflammations) 01/2022 - 01/2019
3	Ulcerative Colitis 01/2022 - 01/2019
3	Melanosis (Freckles) 01/2016 - 01/2012
2	Hyperthermia 01/2022 - 10/2020
2	Infections 05/2021 - 12/2018
2	Breast Neoplasms (Breast Cancer) 03/2021 - 12/2020
2	Body Weight (Weight, Body) 11/2019 - 01/2019
1	Hemorrhage 11/2021
1	Abscess 05/2021
1	Colitis 01/2021
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Pre-Eclampsia (Preeclampsia) 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Arthritis (Polyarthritis) 10/2020
1	Malaria 05/2020
1	Hypertrophic Cicatrix (Hypertrophic Scar) 02/2020
1	Burns 02/2020
1	Warts (Wart) 01/2019
1	Rupture 12/2018
1	Wound Infection (Wound Infections) 10/2018
1	Phenylketonurias (Phenylketonuria) 03/2018
1	Macular Degeneration (Age-Related Maculopathy) 03/2018

Drug/Important Bio-Agent (IBA)

7	HydrogelsIBA 01/2022 - 11/2019
6	Fibroins (Fibroin)IBA 01/2022 - 01/2019
5	ChitosanIBA 01/2022 - 10/2018
5	Proteins (Proteins, Gene)FDA Link 11/2019 - 06/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2018
3	Glutathione (Reduced Glutathione)IBA 01/2022 - 10/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2020
3	AlginatesIBA 01/2022 - 11/2019
2	Tight Junction ProteinsIBA 01/2022 - 11/2019
2	SolutionsIBA 01/2022 - 05/2020
2	Therapeutic UsesIBA 01/2022 - 02/2020
2	artemisinin (artemisinine)IBA 07/2021 - 05/2020
2	CurcuminIBA 03/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 03/2021 - 10/2020
2	Silk FDA Link 11/2019 - 01/2016
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2018 - 10/2018
2	GoldIBA 12/2018 - 10/2018
1	Thrombin FDA Link 10/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 11/2021
1	CytokinesIBA 07/2021
1	IonsIBA 05/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021
1	Hyaluronic Acid (Hyaluronan)IBA 03/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2021
1	carboxymethyl-chitosanIBA 12/2020
1	QuercetinIBA 12/2020
1	Uric Acid (Urate)IBA 10/2020
1	Schiff Bases (Schiff Base)IBA 03/2020
1	Biocompatible Materials (Biomaterials)IBA 03/2020
1	(1-6)-alpha-glucomannan (glucomannan)IBA 03/2020
1	MucinsIBA 11/2019
1	Sericins (Sericin)IBA 11/2019
1	OccludinIBA 11/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	methylallyl trisulfide (MATS)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2018
1	imidazoleIBA 12/2018
1	GelatinIBA 10/2018
1	2-mercapto-1-methylimidazoleIBA 10/2018
1	Excipients (Suspending Agents)IBA 10/2018
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 03/2018
1	sapropterin (tetrahydrobiopterin)FDA Link 03/2018
1	Cyclin D1IBA 01/2018
1	Cyclin-Dependent Kinase 6IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2016
1	CatecholaminesIBA 01/2012
1	Melanins (Melanin)IBA 01/2012

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2015
2	Injections 10/2020 - 03/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Photothermal Therapy 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Tourniquets 11/2021
1	Intravenous Injections 05/2021
1	Combination Drug Therapy (Combination Chemotherapy) 03/2021
1	Oral Administration 11/2019